Information analysis of human splice site mutations

Human Mutation

Volumn 12, Issue 3, 1998, Pages 153-171

  Rogan, Peter K ^a   Faux, Brian M ^a   Schneider, Thomas D ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acceptor; Cryptic; Donor; Information theory; mRNA splicing; Mutation; Polymorphism; Walker

Indexed keywords

ARTICLE; DNA POLYMORPHISM; GENE MUTATION; GENE SEQUENCE; HUMAN; INFORMATION; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

BASE SEQUENCE; HUMANS; MUTATION; RNA SPLICING; RNA, MESSENGER;

EID: 0031880376     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.0.CO;2-I     Document Type: Article

References (136)

1. Ali M, Tuncman G, Cross NC, Vidailhet M, Bokesoy I, Gitzelmann R, Cox TM (1994): Null alleles of the aldolase B gene in patients with hereditary fructose intolerance. J Med Genet 31 499-503.
2. Allikmets R, Wasserman WW, Hutchinson A, Smallwood P, Nathans J, Rogan PK, Schneider TD, Dean M. Organization of the ABCR gene. analysis of promoter and splice junction sequences. Gene, in press.
3. Arredondo-Vega FX, Santisteban I, Kelly S, Schlossman CM, Umetsu DT, Hershfield MS (1994): Correct splicing despite mutation of the invariant first nucleotide of a 5′ splice site: A possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency. Am J Hum Genet 54:820-830.
4. Atweh GF, Anagnou NP, Shearin J, Forget BG, Kaufman RE (1985): Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site. Nucleic Acids Res 13:777-790.
5. Atweh GF, Wong C, Reed R, Antonarakis SE, Zhu D, Ghosh PK, Maniatis T, Forget BG, Kazazian Jr HH (1987): A new mutation in IVS-1 of the human β globin gene causing β thalassemia due to abnormal splicing. Blood 70.147-151.
6. Audrezet MP, Mercier B, Guillermit H, Quere I, Verlingue C, Rault G, Ferec C (1993): Identification of 12 novel mutations in the CFTR gene. Hum Mol Genet 2:51-54.
7. Barbat B, Bogyo A, Raux-Demay MC, Kuttenn F, Boue J, Simon-Bouy B, Serre JL, Mornet E (1995): Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat 5.126-130.
8. Berg OG (1988): Selection of DNA binding sites by regulatory proteins. Functional specificity and pseudosite competition. J Biomol Struct Dyn 6:275-297.
9. Berg OG, von Hippel PH (1987): Selection of DNA binding sites by regulatory proteins, statistical-mechanical theory and application to operators and promoters. J Mol Biol 193:723-750.
10. Berg OG, von Hippel PH (1988a): Selection of DNA binding sites by regulatory proteins. Tr Bio Chem Sci 13:207-211.
11. Berg OG, von Hippel PH (1988b): Selection of DNA binding sites by regulatory proteins. II. The binding specificity of cyclic AMP receptor protein to recognition sites. J Mol Biol 200:709-723.
12. Berget SM (1995): Exon recognition in vertebrate splicing J Biol Chem 270:2411-2414.
13. Bienvenu T, Hubert D, Fonknechten N, Dusser D, Kaplan JC, Beldjord C (1994): Unexpected inactivation of acceptor consensus splice sequence by a-3 C to T transition in intron 2 of the CFTR gene. Hum Genet 94 65-68.
14. Black DL (1991): Does steric interference between splice sites block the splicing of a short c-src neuron-specific exon in non-neuronal cells? Genes Dev 5.389-402.
15. Black DL (1992): Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro Cell 69 795-807.
16. Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, Raben N (1995). Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56 887-897.
17. Bonadio J, Ramirez F, Barr M (1990): An intron mutation in the human α 1 (I) collagen gene alters the efficiency of pre-mRNA spilcing and is associated with osteogenesis imperfecta type II. J Biol Chem 265:2262-2268.
18. Bottema CD, Ketterling RP, Yoon HS, Summer SS (1990): The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians. Am J Hum Genet 47:835-841.
19. Brunak S, Engelbrecht J, Knudsen S (1990): Neural network detects errors in the assignment of mRNA splice sites. Nucl Acids Res 18:4797-4801.
20. Bunge S, Steglich C, Zuther C, Beck M, Morris CP, Schwinger E, Schinzel A, Hopwood JJ, Gal A (1993): Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet 2:1871-1875.
21. Carothers AM, Urlaub G, Grunberger D, Chasin LA (1993): Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol 13:5085-5098.
22. Carstens RP, Fenton WA, Rosenberg LR (1991). Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency. Am J Hum Genet 48.1105-1114.
23. Chibani J, Vidaud M, Duquesnoy P, Berge-Lefranc JL, Pirastu M, Ellouze F, Rosa J, Goossens M (1988): The peculiar spectrum of β-thalassemia genes in Tunisia. Hum Genet 78:190-192.
24. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Férec C, Estivill X (1995). Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332:1475-1480.
25. Chimienti G, Capurso A, Resta F, Pepe G (1992): A G-C change at the donor splice sue of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family. Biochem Biophys Res Commun 187.620-627.
26. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG (1993): Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3:151-156.
27. Cladaras C, Hadzopoulou-Cladaras M, Felber BK, Pavlakis G, Zannis VI (1987): The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene. J Biol Chem 262:2310-2315.
28. Cogan JD, Phillips III JA, Sakati N, Frisch H, Schober E, Milner RD (1993): Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J Clin Endocrinol Metab 76.1224-1228.
29. Cole WG, Chiodo AA, Lamande SR, Janeczko R, Ramirez F, Dahl HH, Chan D, Bateman JF (1990): A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV. J Biol Chem 265:17070-17077.
30. Day DJ, Speiser PW, White PC, Barany F (1995): Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics 29:152-162.
31. Day DJ, Speiser PW, Schulze E, Bettendorf M, Fitness J, Barany F, White PC (1996): Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 5.2039-2048.
32. Dirksen WP, Hampson RK, Sun Q, Rottman FM (1994): A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J Biol Chem 269:6431-6436.
33. Dominski Z, Kole R (1991): Selection of splice sites in pre-mRNAs with short internal exons. Mol Cell Biol 11:6075-6083.
34. Dworniczak B, Aulehla-Scholz C, Kalaydjieva L, Bartholome K, Grudda K, Horst J (1991): Aberrant splicing of phenylalanine hydroxylase mRNA. The major cause for phenylketonuria in parts of southern Europe. Genomics 11:242-246.
35. Eng CM, Resnick-Silverman LA, Niehaus DJ, Astrin KH, Desnick RJ (1993): Nature and frequency of mutations in the α-galactosidase A gene that cause Fabry disease. Am J Hum Genet 53.1186-1197.
36. Flomen RH, Green PM, Bentley DR, Giannelli F, Green EP (1992): Detection of point mutations and a gross deletion in six Hunter syndrome patients. Genomics 13:543-550.
37. Foster DC, Yoshitake S, Davie EW (1985): The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 82:4673-4677.
38. -5 position of intron 33 of the pro-α 2(I) gene (COL1A2) that causes aberrant RNA splicing and lethal osteogenesis impertecta. Use of carbodiimide methods that decrease the extent of DNA sequencing necessary to define an unusual mutation. J Biol Chem 266:12035-12040.
39. Giannelli F, Green PM, High KA, Sommer S, Lillicrap DP, Ludwig M, Olek K, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG (1991): Haemophilia B: Database of point mutations and short additions and deletions-Second edition. Nucleic Acids Res 19:2193-2219.
40. Gibbs RA, Nguyen PN, McBride LJ, Koepf SM, Caskey CT (1989): Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci USA 86:1919-1923.
41. Gibbs RA, Nguyen PN, Edwards A, Civitello AB, Caskey CT (1990): Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics 7.235-244.
42. +-thalassemia globin gene activates splice site in coding sequence RNA. Proc Natl Acad Sci USA 80:2318-2322.
43. Grandchamp B, Picat C, Kauppinen R, Mignotte V, Peltonen L, Mustajoki P, Romeo PH, Goossens M, Nordmann Y (1989a): Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur J Clin Invest 19:415-418.
44. Grandchamp B, Picat C, Mignotte V, Wilson J, TeVelde K, Sandkuyl L, Romeo P, Goossens M, Nordmann Y (1989b): Tissue-specific splicing mutation in acute intermittent porphyria. Proc Natl Acad Sci USA 86:661-664.
45. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990): An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-1269.
46. Hall SL, Padgett RA (1994): Conserved sequences in a class of rare eukaryotic nuclear introns with non-consensus splice sites J Mol Biol 239:357-365.
47. Hata A, Emi M, Luc G, Basdevant A, Gambert P, Iverius PH, Lalouel JM (1990): Compound heterozygote for lipoprotein lipase deficiency: Ser-Thr244 and transition in 3′ splice site of intron 2 (AG-AA) in the lipoprotein lipase gene. Am J Hum Genet 47.721-726.
48. Hawkins JD (1988): A survey on intron and exon lengths. Nucl Acids Res 16.9893-9908.
49. +1 IVS2 splice donor site mutation causing exon 2 skipping in the acid β-glucosidase mRNA. Am J Hum Genet 51:810-820.
50. Hengen PN, Bartram SL, Stewart LE, Schneider TD (1997): Information analysis of Fis binding sites. Nucl Acids Res 25:4994-5002. http://www-lecb.ncifcrf.gov/~toms/paper/fisinfo/
51. Higashi Y, Tanae A, Inoue H, Hiromasa T, Fuju-Kuriyama Y (1988); Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: Possible gene conversion products. Proc Natl Acad Sci USA 85:7486-7490.
52. Ho KK, Kong RY, Kuffner T, Hsu LH, Ma L, Cheah KS (1994): Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII. Hum Mutat 3:358-364.
53. Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, Gal A (1993): Molecular basis of mucopolysaccharidosis type II: Mutations in the iduronate-2-sulphatase gene. Hum Mutat 2:435-442.
54. Horowitz JM, Yandell DW, Park SH, Canning S, Whyte P, Buchkovich K, Harlow E, Weinberg RA, Dryja TP (1989). Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937-940.
55. Hruban RH, van der Riet P, Erozan YS, Sidransky D (1994). Brief report: Molecular biology and the early detection of carcinoma of the bladder - the case of Hubert H. Humphrey. N Engl J Med 330.1276-1278.
56. Huh GS, Hynes RO (1994). Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes Dev 8.1561-1574.
57. +1GT→CT) mutation. Hum Mol Genet 3:2231-2236.
58. Humphrey MB, Bryan J, Cooper TA, Berget SM (1995): A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol Cell Biol 15:3979-3988.
59. Jones CT, McIntosh I, Keston M, Ferguson A, Brock DJ (1992): Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: Analysis of variant splicing and a nonsense mutation. Hum Mol Genet 1:11-17.
60. Jonsson JJ, Aronovich EL, Braun SE, Whitley CB (1995): Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: Toward mutation mapping of the iduronate-2-sulfatase gene. Am J Hum Genet 56:597-607.
61. Kishimoto TK, O'Conner K, Springer TA (1989): Leukocyte adhesion deficiency. Aberrant splicing of a conserved integrin sequence causes a moderate deficiency phenotype. J Biol Chem 264.3588-3595.
62. Kishimoto Y, Murakami Y, Hayashi K, Takahara S, Sugimura T, Sekiya T (1992): Detection of a common mutation of the catalase gene in Japanese acatalasemic patients. Hum Genet 88:487-490.
63. Klein JL, Shows TB, Dupont B, Trapani JA (1989): Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes. Genomics 5:110-117.
64. Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G (1993): A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease J Clin Invest 92:2713-2718.
65. Krawczak M, Reiss J, Cooper DN (1992): The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum Genet 90:41-54.
66. Kudo S, Fukuda M (1989). Structural organization of glycophorin A and B genes. Glycophorin B gene evolved by homologous recombination at Alu repeat sequences. Proc Natl Acad Sci USA 86:4619-4623.
67. Lapoumeroulie C, Acuto S, Rouabhi F, Labie D, Krishnamoorthy R, Bank A (1987): Expression of a β thalassemia gene with abnormal splicing. Nucleic Acids Res 15.8195-8204.
68. Lavigueur A, LaBranche M, Kornblihtt AR, Chabot B (1993): A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev 7:2405-2417.
69. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan XY, Zhang J, Meltzer PS, Yu JW, Kao FT, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin JP, Järvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B (1993): Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225.
70. Lehmann HW, Mundlos S, Winterpacht A, Brenner RE, Zabel B, Muller PK (1994): Ehlers-Danlos syndrome type VII: Phenotype and genotype. Arch Dermatol Res 286:425-428.
71. MacLeod JN, Liebhaber SA, MacGillivray MH, Cooke NE (1991): identification of a splice-site mutation in the human growth hormone-variant gene. Am J Hum Genet 48:1168-1174.
72. -3-to-T donor splice site mutation leads to skipping of exon 50 in von Willebrand factor mRNA. Genomics 24:190-191.
73. Metherall JE, Collins FS, Pan J, Weissman SM, Forget BG (1986). Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron. EMBO J 5:2551-2557.
74. Mount SM (1982): A catalogue of splice junction sequences. Nucl Acids Res 10.459-472.
75. Muntoni S, Wiebusch H, Funke H, Ros E, Seedorf U, Assmann G (1995): Homozygosity for a sptice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet 95:491-494.
76. Nakai K, Sakamoto H (1994). Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 141 171-177.
77. Naylor JA, Green PM, Montandon AJ, Rizza CR, Giannelli F (1991): Detection of three novel mutations in two haemophilia a patients by rapid screening of whole essential region of factor VIII gene. Lancet 337.635-639
78. Neote K, Bapat B, Dumbrille-Ross A, Troxel C, Schuster SM, Mahuran DJ, Gravel RA (1988): Characterization of the human HEXB gene encoding lysosomal β-hexosaminidase. Genomics 3:279-286.
79. Niwa M, MacDonald CC, Berget SM (1992): Are vertebrate exons scanned during splice-site selection? Nature 360:277-280.
80. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR (1994): A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93:1860-1863.
81. O'Neill JP, Rogan PK, Cariello N, Nicklas JA: Mutations that alter RNA splicing of the human HPRT gene: A review of the spectrum. Rev Mutat Res, in press.
82. Ohno K, Suzuki K (1988). A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexosaminidase α chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease. Biochem Biophys Res Commun 153:463-469.
83. Orkin SH, Kazazian Jr HH, Antonarakis SE, Ostrer H, Goff SC, Sexton JP (1982): Abnormal RNA processing due to the exon mutation of β E-globin gene. Nature 300.768-769.
84. Owerbach D, Ballard AL, Draznin MB (1992): Salt-wasting congenital adrenal hyperplasia: Detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction. J Clin Endocrinol Metab 74:553-558.
85. Ozkara HA, Akerman BR, Ciliv G, Topcu M, Renda Y, Gravel RA (1995): Donor splice site mutation in intron 5 of the HEXA gene in a Turkish infant with Tay-Sachs disease. Hum Mutat 5 186-187
86. Phillips III JA, Cogan JD (1994). Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. J Clin Endocrinol Metab 78:11-16.
87. Proia RL (1988): Gene encoding the human β-hexosaminidase β chain: Extensive homology of intron placement in the α- and β-chain genes. Proc Nad Acad Sci USA 85:1883-1887.
88. Purandare SM, Lanyon WG, Arngrimsson R, Connor JM (1995). Characterisation of a novel splice donor mutation affecting position +1 in intron 18 of the NF-1 gene Hum Mol Genet 4:767-768.
89. Rave-Harel M, Kerem E, Nissim-Rafinia M, Madjar I, Goshen R, Augarten A, Rahat A, Hurwitz A, Darvasi A, Kerem B (1997): The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet 60:87-94.
90. Renda M, Maggio A, Warren TC, Kazazian HH (1992): Detection of an IVS-1 3′ end (G-C) β-thalassemia mutation in the AG invariant dinucleotide of the acceptor splice site in a Sicilian subject. Genomics 13:234-235.
91. Robberson BL, Cote GJ, Berget SM (1990): Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 10:84-94.
92. Roberts RG, Bobrow M, Bentley DR (1992): Point mutations in the dystrophin gene. Proc Natl Acad Sci USA 89:2331-2335.
93. Roberts RG, Passos-Bueno MR, Bobrow M, Vainzof M, Zatz M (1993a): Point mutation in a Becker muscular dystrophy patient. Hum Mol Genet 2.75-77.
94. Roberts RG, Bentley DR, Bobrow M (1993b): Infidelity in the structure of ectopic transcripts: A novel exon in lymphocyte dystrophin transcripts. Hum Mutat 2:293-299.
95. Rogan PK, Schneider TD (1995): Using information content and base frequencies to distinguish mutations from genetic polymorphisms in splice junction recognition sites. Hum Mutat 6.74-76.
96. Sakuraba H, Eng CM, Desnick RJ, Bishop DF (1992): Invariant exon skipping in the human α-galactosidase A pre-mRNA: A G+1 to T substitution in a 5′-splice site causing Fabry disease. Genomics 12:643-650.
97. Santisteban I, Arredondo-Vega FX, Kelly S, Mary A, Fischer A, Hummell DS, Lawton A, Sorenson RU, Stiehm ER, Uribe L, Weinberg K, Hershfield MS (1993): Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J Clin Invest 92:2291-2302.
98. Santisteban I, Arredondo-Vega FX, Kelly S, Loubser M, Meydan N, Roifman C, Howell PL, Bowen T, Weinberg KI, Schroeder ML, Hershfield MS (1995): Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes. Implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet 4:2081-2087.
99. Schell U, Hehr A, Feldman GJ, Robin NH, Zackai EH, de Die-Smulders C, Viskochil DH, Stewart JM, Wolff G, Ohashi H, Price RA, Cohen Jr. MM, Muenke M (1995): Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet 4.323-328.
100. Schloesser M, Hofferbert S, Bartz U, Lutze G, Lammle B, Engel W (1995): The novel acceptor splice site mutation 11396(G→A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients. Hum Mol Genet 4:1235-1237.
101. Schneider TD (1991a): Theory of molecular machines. I. Channel capacity of molecular machines. J Theor Biol 148.83-123. http:/ /www-lecb.ncifcrf.gov/~toms/paper/ccmm/
102. Schneider TD (1991b): Theory of molecular machines. II. Energy dissipation from molecular machines. J Theor Biol 148:125-137. http://www-lecb.ncifcrf.gov/~toms/paper/edmm/
103. Schneider TD (1994): Sequence logos, machine/channel capacity, Maxwell's demon, and molecular computers: A review of the theory of molecular machines. Nanotechnology 5:1-18. http:// www-lecb.ncifcrf.gov/~toms/paper/nano2/
104. Schneider TD (1995) Information Theory Primer http://www-lecb.ncifcrf.gov/~toms/paper/primer/
105. Schneider TD (1997a). Information content of individual genetic sequences. J Theor Biol 189:427-441. http://www-lecb.ncifcrf.gov/ ~toms/paper/ri/
106. Schneider TD (1997b). Sequence walkers. A graphical method to display how binding proteins interact with DNA or RNA sequences. Nucl Acids Res 25:4408-4415. http://www-lecb. ncifcrf.gov/~toms/papet/walker/
107. Schneider TD, Stormo GD, Gold L, Ehrenfeucht A (1986): Information content of binding sites on nucleotide sequences. J Mol Biol 188:415-431.
108. Schneider TD, Stormo GD, Haemer JS, Gold L (1982): A design for computer nucleic-acid sequence storage, retrieval and manipulation. Nucl Acids Res 10.3013-3024.
109. Schulze E, Scharer G, Rogatzki A, Priebe L, Lewicka S, Bettendorf M, Hoepffner W, Heinrich UE, Schwabe U (1995). Divergence between genotype and phenotype in relatives of patients with the nitron 2 mutation of steroid-21-hydroxylase. Endocr Res 21:359-364.
110. Senapathy P, Shapiro MB, Harris NL (1990): Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project. Meth Enzym 183:252-278.
111. Shannon CE (1948): A mathematical theory of communication. Bell System Tech J 27:379-423, 623-656.
112. Soria JM, Fontcuberta J, Chillon M, Borrell M, Estivill X, Sala N (1993): Acceptor splice site mutation in the invariant AG of intron 5 of the protein C gene, causing type I protein C deficiency. Hum Genet 92:506-508.
113. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC (1992): Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584-595.
114. +-thalassemic human globin gene. Proc Natl Acad Sci USA 78.2455-2459.
115. Stephens RM, Schneider TD (1992): Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J Mol Biol 228:1124-1136.
116. Sterner DA, Berget SM (1993): In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit Mol Cell Biol 13:2677-2687.
117. Stormo GD, Schneider TD, Gold L, Ehrenfeucht A (1982). Use of the 'Perceptron' algorithm to distinguish translational initiation sites in E. coli. Nucl Acids Res 10.2997-3011.
118. Sun F, Knebelmann B, Pueyo ME, Zouali H, Lesage S, Vaxillaire M, Passa P, Cohen D, Velho G, Antignac C, Froguel P (1993a): Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young. J Clin Invest 92:1174-1180.
119. Sun Q, Mayeda A, Hampson RK, Krainer AR, Rottman FM (1993b): General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev 7:2598-2608.
120. Szilard L (1964) On the decrease of entropy in a thermodynamic system by the intervention of intelligent beings. Behavioral Science 9:301-310.
121. Talerico M, Berget SM (1990). Effect of 5′ splice site mutations on splicing of the preceding intron. Mol Cell Biol 10:6299-6305.
122. Trapani JA, Klein JL, White PC, Dupout B (1988). Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes. Proc Natl Acad Sci USA 85:6924-6928.
123. Treisman R, Orkin SH, Maniatis T (1983): Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature 302:591-596.
124. Tsujino S, Servidei S, Tonin P, Shanske S, Azan G, DiMauro S (1994): Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet 54:812-819.
125. Vasan NS, Kuivamemi H, Vogel BE, Minor RR, Wootton JA, Tromp G, Weksberg R, Prockop DJ (1991): A mutation in the pro α 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: Evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype. Am J Hum Genet 48:305-317.
126. +-thalassemia. Proc Natl Acad Sci USA 86:1041-1045.
127. Wang Z, Hoffmann HM, Grabowski PJ (1995). Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1:21-35.
128. Watson RB, Wallis GA, Holmes DF, Viljoen D, Byers PH, Kadler KE (1992): Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section. J Biol Chem 267.9093-9100.
129. Weil D, D'Alessio M, Ramirez F, de Wet W, Cole WG, Chan D, Bateman JF (1989a): A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII. EMBO J 8.1705-1710
130. Weil D, D'Alessio M, Ramirez F, Steinmann B, Wirtz MK, Glanville RW, Hollister DW (1989b). Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. J Biol Chem 264:16804-16809.
131. Weil D, D'Alessio M, Ramirez F, Eyre DR (1990). Structural and functional characterization of a splicing mutation in the pro-α 2(I) collagen gene of an Ehlers-Danlos type VII patient. J Biol Chem 265.16007-16011.
132. Wen JK, Osumi T, Hashimoto T, Ogata M (1990): Molecular analysis of human acatalasemia. Identification of a splicing mutation. J Mol Biol 211:383-393.
133. Will K, Dork T, Stuhrmann M, Meitinger T, Bertele-Harms R, Tummler B, Schmidtke J (1994). A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis J Clin Invest 93:1852-1859.
134. Wilton SD, Chandler DC, Kakulas BA, Laing NG (1994): Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Hum Mutat 3:133-140.
135. Winterpacht A, Schwarze U, Mundlos S, Menger H, Spranger J, Zabel B (1994): Alternative splicing as the result of a type II procollagen gene (COL2A1) mutation in a patient with Kniest dysplasia. Hum Mol Genet 3:1891-1893.
136. Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie-Rosell A, Buckley EG, Dryja TP (1989): Oncogenic point mutations in the human reunoblastoma gene: Their application to genetic counseling. N Engl J Med 321.1689-1695.